Wu Chun-Hsien, Gan Chin Heng, Li Lan-Hui, Chang Jen-Che, Chen Shin-Tai, Menon Mridula P, Cheng Shu-Meng, Yang Shih-Ping, Ho Chen-Lung, Chernikov Oleg V, Lin Chi-Hung, Lam Yulin, Hua Kuo-Feng
Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan.
Front Immunol. 2020 Dec 18;11:607564. doi: 10.3389/fimmu.2020.607564. eCollection 2020.
Conjugated polyenes are a class of widely occurring natural products with various biological functions. We previously identified 4-hydroxy auxarconjugatin B (4-HAB) as anti-inflammatory agent with an IC of ~20 µM. In this study, we synthesized a new anti-inflammatory 4-HAB analogue, F240B, which has an IC of less than 1 µM. F240B dose-dependently induced autophagy by increasing autophagic flux, LC3 speck formation and acidic vesicular organelle formation. F240B inhibited NACHT, LRR and PYD domain-containing protein 3 (NLRP3) inflammasome activation through autophagy induction. In a mechanistic study, F240B inhibited interleukin (IL)-1β (IL-1β) precursor expression, promoted degradation of NLRP3 and IL-1β, and reduced mitochondrial membrane integrity loss in an autophagy-dependent manner. Additionally, F240B inhibited apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization and speck formation without affecting the interaction between NLRP3 and ASC or NIMA-related kinase 7 (NEK7) and double-stranded RNA-dependent kinase (PKR). Furthermore, F240B exerted anti-inflammatory activity by reducing the intraperitoneal influx of neutrophils and the levels of IL-1β, active caspase-1, IL-6 and monocyte chemoattractant protein-1 (MCP-1) in lavage fluids in a mouse model of uric acid crystal-induced peritonitis. In conclusion, F240B attenuated the NLRP3 inflammasome through autophagy induction and can be developed as an anti-inflammatory agent in the future.
共轭多烯是一类广泛存在的天然产物,具有多种生物学功能。我们之前鉴定出4-羟基奥沙共轭菌素B(4-HAB)为一种抗炎剂,其半数抑制浓度约为20 μM。在本研究中,我们合成了一种新的抗炎4-HAB类似物F240B,其半数抑制浓度小于1 μM。F240B通过增加自噬通量、LC3斑点形成和酸性囊泡细胞器形成,剂量依赖性地诱导自噬。F240B通过自噬诱导抑制含NACHT、LRR和PYD结构域的蛋白3(NLRP3)炎性小体激活。在一项机制研究中,F240B抑制白细胞介素(IL)-1β(IL-1β)前体表达,促进NLRP3和IL-1β的降解,并以自噬依赖性方式减少线粒体膜完整性丧失。此外,F240B抑制含CARD的凋亡相关斑点样蛋白(ASC)寡聚化和斑点形成,而不影响NLRP3与ASC或NIMA相关激酶7(NEK7)与双链RNA依赖性激酶(PKR)之间的相互作用。此外,在尿酸晶体诱导的腹膜炎小鼠模型中,F240B通过减少中性粒细胞向腹腔内的流入以及灌洗液中IL-1β、活化的半胱天冬酶-1、IL-6和单核细胞趋化蛋白-1(MCP-1)的水平发挥抗炎活性。总之,F240B通过自噬诱导减弱NLRP3炎性小体,未来可开发为一种抗炎剂。